Patent References 2887440 3065143 3839319 3852421 3870790 4091205 Novel sustained release tablet formulations Sustained release therapeutic compositions Method and composition for the preparation of controlled long-acting pharmaceuticals Controlled release suppositories InventorsApplicationNo. 06/362104 filed on 03/26/1982US Classes:424/469, Discrete particles in supporting matrix424/480, Cellulose or derivative514/164, With organic oxygen containing compound514/180, 9-position substituted514/192, 1-thia-4-aza-bicyclo (3.2.0) heptane ring containing (including dehydrogenated) (e.g., penicillins, etc.)514/270, Barbituric acid or derivative (including thioanalogs)514/282, One of the five cyclos is five-membered and includes ring chalcogen (e.g., codeine, morphine, etc.)514/304, Tropanes (including nor or dehydro form)514/37, The nitrogen atoms are in N-C(=N)-N groups (e.g., streptomycin, etc.)514/781Cellulose or derivativeExaminersPrimary: Rose, Shep K.Attorney, Agent or FirmInternational ClassesA61K 9/20 (20060101)A61K 9/20 (20060101) AbstractA carrier base material combined with a therapeutically active medicament and shaped and compressed to a solid unit dosage form having a regular and prolonged release pattern upon administration, the carrier base material being one or more hydroxypropylmethylcelluloses or a mixture of one or more hydroxypropylmethylcelluloses and up to 30% by weight of the mixture of methylcellulose, sodium carboxymethylcellulose and/or other cellulose ether, and wherein at least one of the hydroxypropylmethylcelluloses has a methoxy content of 16-24 weight-%, a hydroxypropoxyl content of 4-32 weight-% and a number average molecular weight of at least 50,000 and wherein the carrier base material constitutes less than about one third of the weight of the solid unit dosage form. | |